Llwytho...
Immunotherapy for bladder cancer
It is nearly 40 years since Bacillus Calmette–Guérin (BCG) was first used as an immunotherapy to treat superficial bladder cancer. Despite its limitations, to date it has not been surpassed by any other treatment. As a better understanding of its mechanism of action and the clinical response to it h...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Res Rep Urol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4427258/ https://ncbi.nlm.nih.gov/pubmed/26000263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/RRU.S63447 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|